|
Clinical Trials and Observations
Citations 121-130 of 2742 total displayed.
|
Past content
(since May 1998):
|
Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients
- Jana Pachlopnik Schmid, Despina Moshous, Nathalie Boddaert, Bénédicte Neven, Liliane Dal Cortivo, Marc Tardieu, Marina Cavazzana-Calvo, Stéphane Blanche, Geneviève de Saint Basile, and Alain Fischer
Blood 2009; 114: 211-218.
[Abstract]
[Full text]
[PDF]
How I treat paroxysmal nocturnal hemoglobinuria
- Robert A. Brodsky
Blood 2009; 113: 6522-6527.
[Abstract]
[Full text]
[PDF]
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- Ghada Kchour, Mahdi Tarhini, Mohamad-Mehdi Kooshyar, Hiba El Hajj, Eric Wattel, Mahmoud Mahmoudi, Hassan Hatoum, Hossein Rahimi, Masoud Maleki, Houshang Rafatpanah, S. A. Rahim Rezaee, Mojtaba Tabatabaei Yazdi, Abbas Shirdel, Hugues de Thé, Olivier Hermine, Reza Farid, and Ali Bazarbachi
Blood 2009; 113: 6528-6532.
[Abstract]
[Full text]
[PDF]
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome
- Azra Raza, Naomi Galili, Scott Smith, John Godwin, Jeffrey Lancet, Magda Melchert, Marsha Jones, James G. Keck, Lisa Meng, Gail L. Brown, and Alan List
Blood 2009; 113: 6533-6540.
[Abstract]
[Full text]
[PDF]
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
- Ulrich Keilholz, Anne Letsch, Antonia Busse, Anne Marie Asemissen, Sandra Bauer, Igor Wolfgang Blau, Wolf-Karsten Hofmann, Lutz Uharek, Eckhard Thiel, and Carmen Scheibenbogen
Blood 2009; 113: 6541-6548.
[Abstract]
[Full text]
[PDF]
Cancer in dyskeratosis congenita
- Blanche P. Alter, Neelam Giri, Sharon A. Savage, and Philip S. Rosenberg
Blood 2009; 113: 6549-6557.
[Abstract]
[Full text]
[PDF]
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
- Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Jessica Pollard, Derek L. Stirewalt, Craig Hurwitz, Nyla A. Heerema, Betsy Hirsch, Susana C. Raimondi, Beverly Lange, Janet L. Franklin, Jerald P. Radich, and Soheil Meshinchi
Blood 2009; 113: 6558-6566.
[Abstract]
[Full text]
[PDF]
Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation
- Stephan Metzelder, Ying Wang, Ellen Wollmer, Michael Wanzel, Sabine Teichler, Anuhar Chaturvedi, Martin Eilers, Erich Enghofer, Andreas Neubauer, and Andreas Burchert
Blood 2009; 113: 6567-6571.
[Abstract]
[Full text]
[PDF]
Gene expression profiling of plasma cells at myeloma relapse from tandem transplantation trial Total Therapy 2 predicts subsequent survival
- Bijay Nair, John D. Shaughnessy, Jr, Yiming Zhou, Marie Astrid-Cartron, Pingping Qu, Frits van Rhee, Elias Anaissie, Yazan Alsayed, Sarah Waheed, Klaus Hollmig, Jackie Szymonifka, Nathan Petty, Antje Hoering, and Bart Barlogie
Blood 2009; 113: 6572-6575.
[Abstract]
[Full text]
[PDF]
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
- Irini Sereti, Richard M. Dunham, John Spritzler, Evgenia Aga, Michael A. Proschan, Kathy Medvik, Catherine A. Battaglia, Alan L. Landay, Savita Pahwa, Margaret A. Fischl, David M. Asmuth, Allan R. Tenorio, John D. Altman, Lawrence Fox, Susan Moir, Angela Malaspina, Michel Morre, Renaud Buffet, Guido Silvestri, and Michael M. Lederman, for the ACTG 5214 Study Team
Blood 2009; 113: 6304-6314.
[Abstract]
[Full text]
[PDF]
|
|
